313 Osimertinib tolerance and sustained disease control in recurrent squamous cell lung cancer with rare compound EGFR mutations (G719A and H773L)

Lung Cancer 2026

View at publisher

Authors: Ruqayah Muhammad, Subhra Chowdhury

DOI: 10.1016/j.lungcan.2026.109261

Cited by: 0

References: 2

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Lung Cancer Research Studies

References 2